Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201416327> ?p ?o ?g. }
- W3201416327 abstract "This study aimed to identify new characteristics of elderly onset large-vessel vasculitis (EOLVV) by focusing on human leucocyte antigen (HLA) genotype, polymyalgia rheumatica (PMR), and affected vascular lesions observed on positron emission tomography/computed tomography (PET/CT) imaging.We retrospectively studied 65 consecutive Japanese patients with large-vessel vasculitis (LVV) who had extracranial vasculitis lesions and underwent PET/CT imaging. PET/CT images were assessed using the semi-quantitative PET visual score of each affected vessel, and the PET vascular activity score (PETVAS) and number of affected vessels were calculated. Subjects were subsequently grouped based on age at onset, superficial temporal artery (STA) involvement, and presence of PMR and compared each group according to HLA genotype. Unsupervised hierarchical cluster analysis was used to identify the patients with similar characteristics in terms of affected vascular lesions detected through PET/CT imaging. The clinical characteristics and PET/CT findings of the population newly identified in this study were examined.Twenty-seven patients with EOLVV did not meet the American College of Rheumatology 1990 criteria for giant cell arteritis (GCA) and Takayasu arteritis and were considered as unclassified EOLVV (UEOLVV). The unsupervised hierarchical cluster analysis revealed that UEOLVV with PMR and large-vessel GCA (LV-GCA) formed a cluster of LVV with GCA features (i.e., PMR and/or STA involvement) when restricted to patients who were HLA-B52-positive. Patients who were HLA-B52-positive with LVV and GCA features had similar clinical characteristics and patterns of affected vessels and presented with diffuse LVV lesions. HLA-B52-positive patients who had LVV with GCA features also presented with higher PETVAS, more affected vessels, and lower rates of biologics usage and relapse compared to HLA-B52-positive patients with TAK.Patients who had UEOLVV with PMR had similar characteristics to patients with LV-GCA. Patients who were HLA-B52-positive and had LVV with GCA features presented with diffuse vascular lesions and may comprise a core population of Japanese patients with EOLVV. The findings of HLA-B52 positivity and diffusely affected vessels in patients with EOLVV can be considered as suspicious findings of LV-GCA." @default.
- W3201416327 created "2021-09-27" @default.
- W3201416327 creator A5013618903 @default.
- W3201416327 creator A5020403199 @default.
- W3201416327 creator A5024581419 @default.
- W3201416327 creator A5026278665 @default.
- W3201416327 creator A5030740263 @default.
- W3201416327 creator A5050988600 @default.
- W3201416327 creator A5064060072 @default.
- W3201416327 creator A5064973929 @default.
- W3201416327 creator A5077117032 @default.
- W3201416327 creator A5077232803 @default.
- W3201416327 creator A5090079950 @default.
- W3201416327 date "2021-09-13" @default.
- W3201416327 modified "2023-10-05" @default.
- W3201416327 title "HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study" @default.
- W3201416327 cites W1908449555 @default.
- W3201416327 cites W1926345360 @default.
- W3201416327 cites W1976223575 @default.
- W3201416327 cites W1981729580 @default.
- W3201416327 cites W1987316799 @default.
- W3201416327 cites W1993289300 @default.
- W3201416327 cites W1996218107 @default.
- W3201416327 cites W2017295541 @default.
- W3201416327 cites W2031517139 @default.
- W3201416327 cites W2051461792 @default.
- W3201416327 cites W2075769019 @default.
- W3201416327 cites W2098959715 @default.
- W3201416327 cites W2102802921 @default.
- W3201416327 cites W2105882374 @default.
- W3201416327 cites W2144768521 @default.
- W3201416327 cites W2146119217 @default.
- W3201416327 cites W2169058648 @default.
- W3201416327 cites W2238339241 @default.
- W3201416327 cites W2337240497 @default.
- W3201416327 cites W2512606343 @default.
- W3201416327 cites W2769898966 @default.
- W3201416327 cites W2795576082 @default.
- W3201416327 cites W2896711326 @default.
- W3201416327 cites W2913963312 @default.
- W3201416327 cites W2921980972 @default.
- W3201416327 cites W2969356927 @default.
- W3201416327 cites W3035819652 @default.
- W3201416327 cites W4211106135 @default.
- W3201416327 cites W4238228430 @default.
- W3201416327 doi "https://doi.org/10.1186/s13075-021-02618-4" @default.
- W3201416327 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8436550" @default.
- W3201416327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34517892" @default.
- W3201416327 hasPublicationYear "2021" @default.
- W3201416327 type Work @default.
- W3201416327 sameAs 3201416327 @default.
- W3201416327 citedByCount "1" @default.
- W3201416327 countsByYear W32014163272021 @default.
- W3201416327 crossrefType "journal-article" @default.
- W3201416327 hasAuthorship W3201416327A5013618903 @default.
- W3201416327 hasAuthorship W3201416327A5020403199 @default.
- W3201416327 hasAuthorship W3201416327A5024581419 @default.
- W3201416327 hasAuthorship W3201416327A5026278665 @default.
- W3201416327 hasAuthorship W3201416327A5030740263 @default.
- W3201416327 hasAuthorship W3201416327A5050988600 @default.
- W3201416327 hasAuthorship W3201416327A5064060072 @default.
- W3201416327 hasAuthorship W3201416327A5064973929 @default.
- W3201416327 hasAuthorship W3201416327A5077117032 @default.
- W3201416327 hasAuthorship W3201416327A5077232803 @default.
- W3201416327 hasAuthorship W3201416327A5090079950 @default.
- W3201416327 hasBestOaLocation W32014163271 @default.
- W3201416327 hasConcept C126838900 @default.
- W3201416327 hasConcept C142724271 @default.
- W3201416327 hasConcept C2775842073 @default.
- W3201416327 hasConcept C2776015282 @default.
- W3201416327 hasConcept C2776712624 @default.
- W3201416327 hasConcept C2779134260 @default.
- W3201416327 hasConcept C2780079024 @default.
- W3201416327 hasConcept C2781343717 @default.
- W3201416327 hasConcept C2989005 @default.
- W3201416327 hasConcept C3019145103 @default.
- W3201416327 hasConcept C71924100 @default.
- W3201416327 hasConceptScore W3201416327C126838900 @default.
- W3201416327 hasConceptScore W3201416327C142724271 @default.
- W3201416327 hasConceptScore W3201416327C2775842073 @default.
- W3201416327 hasConceptScore W3201416327C2776015282 @default.
- W3201416327 hasConceptScore W3201416327C2776712624 @default.
- W3201416327 hasConceptScore W3201416327C2779134260 @default.
- W3201416327 hasConceptScore W3201416327C2780079024 @default.
- W3201416327 hasConceptScore W3201416327C2781343717 @default.
- W3201416327 hasConceptScore W3201416327C2989005 @default.
- W3201416327 hasConceptScore W3201416327C3019145103 @default.
- W3201416327 hasConceptScore W3201416327C71924100 @default.
- W3201416327 hasIssue "1" @default.
- W3201416327 hasLocation W32014163271 @default.
- W3201416327 hasLocation W32014163272 @default.
- W3201416327 hasLocation W32014163273 @default.
- W3201416327 hasLocation W32014163274 @default.
- W3201416327 hasLocation W32014163275 @default.
- W3201416327 hasOpenAccess W3201416327 @default.
- W3201416327 hasPrimaryLocation W32014163271 @default.
- W3201416327 hasRelatedWork W1484621988 @default.
- W3201416327 hasRelatedWork W1978229966 @default.
- W3201416327 hasRelatedWork W2094835078 @default.
- W3201416327 hasRelatedWork W2110883880 @default.